Cubist Systematic Strategies, LLC Collegium Pharmaceutical, Inc Transaction History

Cubist Systematic Strategies, LLC

$17.3 Billion
Q1 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 92,992 shares of COLL stock, worth $2.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

92,992

Previous 72,329 28.57%

Holding current value

$2.99 Million

Previous $2.23 Million 62.13%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $645,305 - $845,323	20,663 Added 28.57%	92,992 $3.61 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $123,278 - $179,440	-5,826 Reduced 7.45%	72,329 $2.23 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $1.66 Million - $1.9 Million	78,155 New	78,155 $1.75 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $4.51 Million - $5.86 Million	196,096 New	196,096 $4.7 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $1.01 Million - $1.32 Million	65,578 New	65,578 $1.05 Million

Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $1.07 Million - $1.56 Million	-74,897 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $782,084 - $1.02 Million	45,470 Added 154.52%	74,897 $1.53 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $204,365 - $249,325	-11,678 Reduced 28.41%	29,427 $550,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $135,255 - $193,471	-7,620 Reduced 15.64%	41,105 $811,000
Q2 2021 Aug 16, 2021	SELL	$21.74 - $25.28 $147,745 - $171,802	-6,796 Reduced 12.24%	48,725 $1.15 Million
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $639,523 - $867,094	33,222 Added 148.98%	55,521 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $183,559 - $229,475	-10,295 Reduced 31.59%	22,299 $447,000
Q3 2020 Nov 16, 2020	BUY	$15.78 - $20.82 $11,708 - $15,448	742 Added 2.33%	32,594 $679,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $577,296 - $876,194	-37,269 Reduced 53.92%	31,852 $557,000
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $526,208 - $964,147	37,884 Added 121.28%	69,121 $1.13 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $334,235 - $694,710	31,237 New	31,237 $643,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $353,093 - $551,584	-33,248 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $451,507 - $622,402	33,248 New	33,248 $503,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $152,367 - $202,881	-10,309 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $19,583 - $33,606	1,383 Added 15.49%	10,309 $152,000
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $194,497 - $252,516	8,926 New	8,926 $213,000

Others Institutions Holding COLL

# of Institutions

231

Shares Held

39.5M

Call Options Held

104K

Put Options Held

15.4K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Collegium Pharmaceutical, Inc Transaction History